Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-11 Sale |
2022-03-15 8:57 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
336,150 | $6.4757 | $2,176,801 | 24,683,337 (Indirect Direct) |
View |
| 2022-03-07 Sale |
2022-03-09 8:44 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
300,000 | $7.2965 | $2,188,950 | 10,732,519 (Indirect Direct) |
View |
| 2022-02-22 Sale |
2022-02-24 7:24 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
100,000 | $10.22 | $1,021,540 | 11,032,519 (Indirect Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 8:09 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
19,858 | $11.73 | $232,964 | 10,500,183 (Indirect Direct) |
View |
| 2022-01-13 Sale |
2022-01-14 8:42 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
341,000 | $13.76 | $4,692,177 | 26,671,725 (Indirect Direct) |
View |
| 2022-01-04 Sale |
2022-01-05 8:39 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
9,625 | $18.03 | $173,528 | 7,651,146 (Direct) |
View |
| 2021-12-21 Sale |
2021-12-23 5:05 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
9,625 | $18.75 | $180,478 | 7,660,216 (Direct) |
View |
| 2021-12-16 Sale |
2021-12-20 6:00 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
2,500 | $18.74 | $46,848 | 47,500 (Direct) |
View |
| 2021-12-16 Sale |
2021-12-20 5:59 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
200 | $20 | $4,001 | 10,936,041 (Indirect Direct) |
View |
| 2021-12-13 Sale |
2021-12-15 8:01 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
100 | $20.02 | $2,002 | 10,936,241 (Indirect Direct) |
View |
| 2021-12-08 Sale |
2021-12-10 9:42 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
11,750 | $20.13 | $236,562 | 19,132,069 (Indirect Direct) |
View |
| 2021-12-07 Sale |
2021-12-09 9:52 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
19,792 | $20.48 | $405,433 | 8,348,091 (Indirect Direct) |
View |
| 2021-12-07 Sale |
2021-12-09 9:23 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
9,625 | $20.32 | $195,533 | 7,669,841 (Direct) |
View |
| 2021-12-07 Sale |
2021-12-09 9:21 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
15,900 | $20.48 | $325,630 | 3,784,311 (Indirect Direct) |
View |
| 2021-11-17 Sale(A) |
2021-12-09 9:17 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
19,100 | $20.16 | $384,962 | 1,928,163 (Indirect Direct) |
View |
| 2021-11-18 Sale |
2021-11-22 8:23 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
2,500 | $18.92 | $47,308 | 50,000 (Direct) |
View |
| 2021-11-18 Sale |
2021-11-22 8:20 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
9,625 | $18.91 | $182,005 | 7,679,466 (Direct) |
View |
| 2021-11-17 Sale |
2021-11-19 5:40 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
19,100 | $20.16 | $384,962 | 3,800,211 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-04-01 Option Award |
2022-04-05 7:23 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
1,788 | $0 | 136,373 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-05 7:22 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | CHAVEZ R. MARTIN Director |
2,438 | $0 | 11,107 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-05 7:21 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,544 | $0 | 5,102,514 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-04 4:06 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
9,072 | $0 | 873,080 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-04 4:06 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
9,072 | $2.48 | 873,080 (Direct) |
View |
| 2022-03-11 Conversion |
2022-03-15 8:57 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
336,150 | $0 | 24,683,337 (Direct) |
View |
| 2022-03-07 Conversion |
2022-03-09 8:44 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
300,000 | $0 | 10,732,519 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 8:55 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
58,500 | $0 | 1,156,028 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 8:55 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
58,500 | $1.06 | 1,156,028 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-01 8:00 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
15,625 | $0 | 873,080 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-01 8:00 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
15,625 | $2.48 | 873,080 (Direct) |
View |
| 2022-02-22 Conversion |
2022-02-24 7:24 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
100,000 | $0 | 11,032,519 (Direct) |
View |
| 2022-02-18 Exercise |
2022-02-22 7:58 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
16,000 | $0 | 1,156,028 (Direct) |
View |
| 2022-02-18 Exercise |
2022-02-22 7:58 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
16,000 | $1.06 | 1,156,028 (Direct) |
View |
| 2022-02-14 Exercise |
2022-02-17 06:04 am |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
4,000 | $0 | 1,156,028 (Direct) |
View |
| 2022-02-14 Exercise |
2022-02-17 06:04 am |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
4,000 | $1.06 | 1,156,028 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 9:11 pm |
N/A 2032-02-04 |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Corp. Dev. Officer |
128,829 | $0 | 878,097 (Direct) |
View |
| 2022-02-04 Tax Withholding |
2022-02-08 9:11 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Corp. Dev. Officer |
1,114 | $11.4 | 878,097 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 9:09 pm |
N/A 2032-02-04 |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
122,673 | $0 | 873,080 (Direct) |
View |
| 2022-02-04 Tax Withholding |
2022-02-08 9:09 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
981 | $11.4 | 873,080 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 9:07 pm |
N/A 2032-02-04 |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
180,897 | $0 | 3,030,682 (Direct) |
View |
| 2022-02-04 Tax Withholding |
2022-02-08 9:07 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
678 | $11.4 | 3,030,682 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 9:05 pm |
N/A 2032-02-04 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
246,015 | $0 | 1,156,028 (Direct) |
View |
| 2022-02-04 Tax Withholding |
2022-02-08 9:05 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
828 | $11.4 | 1,156,028 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 9:03 pm |
N/A 2032-02-04 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
632,679 | $0 | 11,132,519 (Direct) |
View |
| 2022-02-04 Tax Withholding |
2022-02-08 9:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
343 | $11.4 | 11,132,519 (Direct) |
View |
| 2022-01-31 Exercise |
2022-02-02 8:11 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
15,625 | $0 | 751,388 (Direct) |
View |
| 2022-01-31 Exercise |
2022-02-02 8:11 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
15,625 | $2.48 | 751,388 (Direct) |
View |
| 2022-01-31 Conversion |
2022-02-02 8:09 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
19,858 | $0 | 10,500,183 (Direct) |
View |
| 2021-12-28 Gift |
2022-01-14 8:42 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
75,000 | $0 | 26,671,725 (Direct) |
View |
| 2022-01-13 Conversion |
2022-01-14 8:42 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
341,000 | $0 | 26,671,725 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 8:48 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
40,322 | $0 | 750,000 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 8:48 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
40,322 | $2.47 | 750,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:46 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
659 | $0 | 5,100,970 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:45 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | HERSHBERG ROBERT Director |
693 | $0 | 7,862 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:43 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | CHAVEZ R. MARTIN Director |
1,040 | $0 | 8,669 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:41 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
763 | $0 | 134,585 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:39 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
555 | $0 | 7,651,146 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:38 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Bogue Zachary Director 10% Owner |
589 | $0 | 13,620,594 (Direct) |
View |
| 2021-12-16 Conversion |
2021-12-20 5:59 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
200 | $0 | 10,936,041 (Direct) |
View |
| 2021-12-13 Conversion |
2021-12-15 8:01 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
100 | $0 | 10,936,241 (Direct) |
View |
| 2021-12-08 Exercise |
2021-12-10 9:42 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
28,646 | $0 | 19,132,069 (Direct) |
View |
| 2021-12-08 Exercise |
2021-12-10 9:42 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
28,646 | $2.47 | 19,132,069 (Direct) |
View |
| 2021-12-08 Conversion |
2021-12-10 9:42 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
6,574 | $0 | 19,132,069 (Direct) |
View |
| 2021-11-21 Gift |
2021-12-09 9:52 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
1,650,000 | $0 | 8,348,091 (Direct) |
View |
| 2021-12-07 Other |
2021-12-09 9:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director |
3,599 | $0 | 7,198 (Direct) |
View |
| 2021-12-07 Other |
2021-12-09 8:57 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Lux Ventures IV L.P. Lux Venture Partners IV LLC Lux Co-Invest Opportunities L.P. Lux Co-Invest Partners LLC Hebert Peter Wolfe Josh Former 10% Owner |
4,265,576 | $0 | 17,287,095 (Direct) |
View |